BIIB Stock Forecast: Biogen Inc. Skyrockets As New Drug Brings Hope For Alzheimer’s Patients

  This article was written by Julia Masch, a Financial Analyst at I Know First.  



Alzheimer's is a disease for which there is no effective treatment whatsoever. To be clear, there is no pharmaceutical agent, no magic pill that a doctor can prescribe that will have any significant effect on the progressive downhill course of this disease” -Dr. David Permutter

Highlights

  • Ban-2401 Brings Hope To Alzheimer's Patients
  • Another Alzheimer's Drug In The Works: Aducanumab
  • Current Bullish I Know First Forecast For BIIB

premiumRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content here

Equity Research Based On Algorithms: Up to 116.25% Return in 3 Months

Package Name: Industry Package - Biotech Stocks
Forecast Length: 3 Months (5/03/15 – 8/03/15)
I Know First Average: 19.08%

Read The Full Forecast

Equity Research

Biotech Stocks to Watch: Up to 46.34% Return in 1 Month

Package Name: Industry Package - Biotech Stocks
Forecast Length: 1 Month (6/26/15 – 7/26/15)
I Know First Average: 4.04% (Long) and 5.92% (Short)

Read The Full Forecast

Biotech Stocks To Watch

Biotech Stocks To Watch: Up To 14.96% In 1 Month

Package Name: Industry Package - Biotech Stocks
Recommended Positions: Long 
24 07 2013 10 48 51 Best Investments Based on Algorithms: 8.19% Gain in 14 DaysForecast Length: 1 Month (4/30/15 – 5/30/15)
I Know First Average: 4.74%

Read The Full Forecast

biotech stocks to watch